EW · Edwards Lifesciences Corp · Documents
$88.29
+1.07 (+1.23%)
At close · Oct 20
Return incl. dividend (before tax)
Market Cap
$50.89B
Shares
576.40M
Volume · Oct 20
1.8M
Avg daily vol (3M)
3.67M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2020-10-22 | 2020-10-21 | |
| 10-Q | — | 2020-07-27 | 2020-06-30 | |
| 8-K | — | 2020-07-23 | — | |
| 8-K | — | 2020-07-15 | 2020-07-13 | |
| 8-K | — | 2020-07-13 | — | |
| 8-K | — | 2020-05-08 | 2020-05-07 | |
| 10-Q | — | 2020-04-28 | 2020-03-31 | |
| 8-K | — | 2020-04-23 | — | |
| DEFA14A | — | 2020-04-13 | — | |
| DEF 14A | — | 2020-03-25 | 2020-05-07 | |
| DEFA14A | — | 2020-03-25 | — | |
| DEFA14A | — | 2020-03-25 | — | |
| PRE 14A | — | 2020-03-09 | 2020-05-07 | |
| 10-K | — | 2020-02-14 | 2019-12-31 | |
| 8-K | — | 2020-01-30 | — |
Showing 101–115 of 115 filings
Key facts
CIK
1099800
CUSIP
28176E108
13F (30d)
253 filings
236 filers
Visit website
Investor relations